Related Experiment Video

Updated: Aug 13, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Depression and stages of Huntington's disease

Jane S Paulsen1, Carissa Nehl, Karin Ferneyhough Hoth

  • 1University of Iowa, 1-305 Medical Education Building, Iowa City, IA 52242, USA. jane-paulsen@uiowa.edu

The Journal of Neuropsychiatry and Clinical Neurosciences
|January 3, 2006
PubMed

Insights

Depression is common in Huntington's disease (HD), affecting over twice the general population. Treatment is underutilized, despite significant impact and suicide risk in HD patients.

Area of Science:

  • Neurology
  • Psychiatry
  • Genetics

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder.
  • Depression is a common and significant comorbidity in HD.
  • Understanding depression's trajectory in HD is crucial for patient care.

Purpose of the Study:

  • To characterize depression symptoms in individuals with manifest Huntington's disease.
  • To examine the relationship between depression and disease progression in HD.
  • To assess treatment seeking and utilization for depression in HD.

Main Methods:

  • Cross-sectional interviews with individuals diagnosed with manifest Huntington's disease.
  • Assessment of depression symptom presence, frequency, and severity.
  • Inquiry into prior treatment seeking for depression and suicide attempts.

Main Results:

  • Depression rates in HD were more than double those in the general population.
  • Half of HD patients reported seeking treatment for depression; over 10% reported suicide attempts.
  • The prevalence of significant depression symptoms decreased as HD progressed.

Conclusions:

  • Depression is a major public health concern in Huntington's disease.
  • Standard depression treatments are underutilized in the HD population.
  • Further research is needed to establish the efficacy of depression treatments in HD.

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...